Sustainability & Climate

Ottawa's National Gallery unveils new exhibits and family fun with free admission for youth, blending high art with interactive holiday experiences.

Facing a critical cash shortfall, Cue Biopharma turns to the market, betting its promising cancer and autoimmune pipeline can win over investors.

An executive order accelerates moving cannabis to Schedule III, promising massive tax breaks for businesses but leaving advocates wanting more federal reform.

For the first time, Medicare and Medicaid will cover CBD products for senior cancer patients, a landmark decision with massive implications for patients and markets.

Facing financial headwinds, Celularity lands a critical $12M from a top investor to push its ambitious anti-aging and regenerative therapies forward.

A new standing wheelchair module offers unprecedented height, blending advanced engineering with profound health and social benefits for users.

As pharma sells GLP-1s directly to patients, doctors are split on the new model. Is it a lifeline for access or a risk to integrated patient care?

Trinity Investments expands its European empire, acquiring The Hoxton, Poblenou in a move that highlights its multi-segment strategy in top-tier markets.

With the hire of a digital leader from brands like Google and Sonos, Unlock Health aims to bring modern, user-friendly tech to the healthcare industry.

As LunR Royalties begins trading, its parent NGEx Minerals pivots to unlock the potential of its world-class copper-gold assets in South America.

$8.4M in Home4Good grants will fund 110 programs in DE, PA, and WV, offering a lifeline as housing insecurity deepens across the region.

An expert shares urgent year-end tips on charitable giving, portfolio rebalancing, and college savings to maximize benefits before new tax laws take effect.

Millions struggle to swallow pills. Azurity's new FDA-approved liquid hypertension drug, Javadin, offers a ready-to-use solution for better adherence.

Medical cannabis firm Crucial Innovations retains FOCUS Capital Partners, signaling a push for institutional investment and a potential 2026 US listing.

A $1.9M real estate deal for a Pennsylvania vet clinic reveals how UPREIT exchanges help practice owners unlock capital tax-efficiently while securing care.

Picard Medical rings the NYSE bell, but its stock's volatile journey reflects the high-stakes gamble on its next-generation artificial heart technology.

The biotech upstart will present a bold pipeline, including a head-to-head trial against a market leader and a first-in-class autoimmune eye disease therapy.

Leaders from PepsiCo, Unilever, and Kraft Heinz are guiding FourKites' AI roadmap to build more resilient and automated consumer goods supply chains.

Leveraging a fleet of vintage F-104 jets, Starfighters Space raises $40M and goes public, aiming to disrupt the small satellite launch market.

Johnson & Johnson's TRUFILL n-BCA gains FDA approval for chronic subdural hematoma, offering a minimally invasive option to curb high rates of recurrence.